Skip to main content
Erschienen in: International Journal of Colorectal Disease 5/2004

01.09.2004 | Original Article

Interferon gamma downregulates IL-8 production in primary human colonic epithelial cells without induction of apoptosis

verfasst von: K. Schlottmann, F.-P. Wachs, J. Grossmann, D. Vogl, M. Maendel, W. Falk, J. Schölmerich, T. Andus, G. Rogler

Erschienen in: International Journal of Colorectal Disease | Ausgabe 5/2004

Einloggen, um Zugang zu erhalten

Abstract

Background

In acute or chronic inflammatory bowel disease (IBD) interferon gamma (IFNγ) is still considered to be an important pro-inflammatory mediator. In the present study we investigated the impact of IFNγ on interleukin-8 (IL-8) production as a read-out for cell activation in intestinal epithelial cell (IEC) lines and primary human colonic epithelial cells (CEC).

Methods

Primary cultures of human CEC were established from the mucosa of patients without inflammatory disease. CEC, HT-29 or Caco-2 cells were incubated with either IFNγ, tumor necrosis factor (TNF)α or IL-10. IL-8 and IL-1Ra secretion was determined by ELISA. Competicon PCR was used for quantification of IL-8mRNA. Apoptosis was quantified by propidium iodine incorporation and fluorescence activated cell sorting (FACS) analysis.

Results

In contrast to HT-29 cells in primary human CEC 100 U/ml IFNγ inhibited IL-8 secretion significantly to 70±15% of unstimulated primary CEC (p<0.005) more effectively than IL-10 (87±21% versus unstimulated cells, n.s.). In HT-29 cells, IL-8 secretion was induced to 405±101% of unstimulated cells. In Caco-2 cells, IFNγ had no significant effect on IL-8 secretion. The effect in HT-29 and CEC was concentration dependent. In primary CEC, 200 U/ml IFNγ further reduced IL-8 secretion to 48±18% of unstimulated CEC (p<0.05). Whereas IL-8 mRNA was strongly upregulated in HT-29 cells, no upregulation or even a downregulation was found in CEC. Pre-incubation with 100 U/ml IFNγ did not increase the susceptibility to apoptosis mediated by anti-Fas antibody (CH-11) in primary CEC, whereas HT-29 cells showed increased rates of apoptosis after priming with IFNγ.

Conclusion

In contrast to HT-29, IFNγ downregulated IL-8 secretion and did not induce IL-8 mRNA expression in primary human CEC. This effect was not due to induction of apoptosis.
Literatur
1.
Zurück zum Zitat Tidball CS (1971) The nature of the intestinal epithelial barrier. Am J Dig Dis 16:745–767PubMed Tidball CS (1971) The nature of the intestinal epithelial barrier. Am J Dig Dis 16:745–767PubMed
2.
Zurück zum Zitat Gibson P, Anderson R, Mariadason J, Wilson A (1996) Protective role of the epithelium of the small intestine and colon. Inflamm Bowel Dis 2:279–302 Gibson P, Anderson R, Mariadason J, Wilson A (1996) Protective role of the epithelium of the small intestine and colon. Inflamm Bowel Dis 2:279–302
3.
Zurück zum Zitat Kraehenbuhl JP, Pringault E, Neutra MR (1997) Intestinal epithelia and barrier functions. Aliment Pharmacol Ther 11:3–9 Kraehenbuhl JP, Pringault E, Neutra MR (1997) Intestinal epithelia and barrier functions. Aliment Pharmacol Ther 11:3–9
4.
Zurück zum Zitat Podolsky DK (1999) Mucosal immunity and inflammation. Innate mechanisms of mucosal defense and repair: the best offense is a good defense. Am J Physiol 277:G495–499PubMed Podolsky DK (1999) Mucosal immunity and inflammation. Innate mechanisms of mucosal defense and repair: the best offense is a good defense. Am J Physiol 277:G495–499PubMed
5.
Zurück zum Zitat Maaser C, Kagnoff MF (2002) Role of the intestinal epithelium in orchestrating innate and adaptive mucosal immunity. Z Gastroenterol 40:525–529CrossRefPubMed Maaser C, Kagnoff MF (2002) Role of the intestinal epithelium in orchestrating innate and adaptive mucosal immunity. Z Gastroenterol 40:525–529CrossRefPubMed
6.
Zurück zum Zitat Hamzaoui N, Pringault E (1998) Interaction of microorganisms, epithelium, and lymphoid cells of the mucosa-associated lymphoid tissue. Ann N Y Acad Sci 859:65–74PubMed Hamzaoui N, Pringault E (1998) Interaction of microorganisms, epithelium, and lymphoid cells of the mucosa-associated lymphoid tissue. Ann N Y Acad Sci 859:65–74PubMed
7.
Zurück zum Zitat Strober W (1998) Interactions between epithelial cells and immune cells in the intestine. Ann N Y Acad Sci 859:37–45PubMed Strober W (1998) Interactions between epithelial cells and immune cells in the intestine. Ann N Y Acad Sci 859:37–45PubMed
8.
Zurück zum Zitat Christ A, Blumberg R (1997) The intestinal epithelial cell: immunological aspects. Springer Semin Immunopathol 18:449–461PubMed Christ A, Blumberg R (1997) The intestinal epithelial cell: immunological aspects. Springer Semin Immunopathol 18:449–461PubMed
9.
Zurück zum Zitat Selby WS, Poulter LW, Hobbs S, Jewell DP (1981) Expression of HLA-DR antigens by colonic epithelium in inflammatory bowel disease. Clin Exp Immunol 44:453–458PubMed Selby WS, Poulter LW, Hobbs S, Jewell DP (1981) Expression of HLA-DR antigens by colonic epithelium in inflammatory bowel disease. Clin Exp Immunol 44:453–458PubMed
10.
Zurück zum Zitat Mayer L, Eisenhardt D, Salomon P, Bauer W, Plous R, Piccinini L (1991) Expression of class II molecules on intestinal epithelial cells in humans. Differences between normal and inflammatory bowel disease. Gastroenterology 100:3–12 Mayer L, Eisenhardt D, Salomon P, Bauer W, Plous R, Piccinini L (1991) Expression of class II molecules on intestinal epithelial cells in humans. Differences between normal and inflammatory bowel disease. Gastroenterology 100:3–12
11.
Zurück zum Zitat Mayer L (2000) Mucosal immunity and gastrointestinal antigen processing. J Pediatr Gastroenterol Nutr 30:S4–S12CrossRefPubMed Mayer L (2000) Mucosal immunity and gastrointestinal antigen processing. J Pediatr Gastroenterol Nutr 30:S4–S12CrossRefPubMed
12.
Zurück zum Zitat Kaiserlian D, Rigal D, Abello J, Revillard JP (1991) Expression, function and regulation of the intercellular adhesion molecule-1 (ICAM-1) on human intestinal epithelial cell lines. Eur J Immunol 21:2415–2421PubMed Kaiserlian D, Rigal D, Abello J, Revillard JP (1991) Expression, function and regulation of the intercellular adhesion molecule-1 (ICAM-1) on human intestinal epithelial cell lines. Eur J Immunol 21:2415–2421PubMed
13.
Zurück zum Zitat Kvale D, Krajci P, Brandtzaeg P (1992) Expression and regulation of adhesion molecules ICAM-1 (CD54) and LFA-3 (CD58) in human intestinal epithelial cell lines. Scand J Immunol 35:669–676PubMed Kvale D, Krajci P, Brandtzaeg P (1992) Expression and regulation of adhesion molecules ICAM-1 (CD54) and LFA-3 (CD58) in human intestinal epithelial cell lines. Scand J Immunol 35:669–676PubMed
14.
Zurück zum Zitat Dippold W, Wittig B, Schwaeble W, Mayet W, Meyer zum Buschenfelde KH (1993) Expression of intercellular adhesion molecule 1 (ICAM-1, CD54) in colonic epithelial cells. Gut 34:1593–1597PubMed Dippold W, Wittig B, Schwaeble W, Mayet W, Meyer zum Buschenfelde KH (1993) Expression of intercellular adhesion molecule 1 (ICAM-1, CD54) in colonic epithelial cells. Gut 34:1593–1597PubMed
15.
Zurück zum Zitat Jung HC, Eckmann L, Yang SK, Panja A, Fierer J, Morzycka-Wroblewska E, Kagnoff MF (1995) A distinct array of proinflammatory cytokines is expressed in human colon epithelial cells in response to bacterial invasion. J Clin Invest 95:55–65PubMed Jung HC, Eckmann L, Yang SK, Panja A, Fierer J, Morzycka-Wroblewska E, Kagnoff MF (1995) A distinct array of proinflammatory cytokines is expressed in human colon epithelial cells in response to bacterial invasion. J Clin Invest 95:55–65PubMed
16.
Zurück zum Zitat Eckmann L, Jung HC, Schurer-Maly C, Panja A, Morzycka-Wroblewska E, Kagnoff MF (1993) Differential cytokine expression by human intestinal epithelial cell lines: regulated expression of interleukin 8. Gastroenterology 105:1689–1697PubMed Eckmann L, Jung HC, Schurer-Maly C, Panja A, Morzycka-Wroblewska E, Kagnoff MF (1993) Differential cytokine expression by human intestinal epithelial cell lines: regulated expression of interleukin 8. Gastroenterology 105:1689–1697PubMed
17.
Zurück zum Zitat Eckmann L, Kagnoff MF, Fierer J (1993) Epithelial cells secrete the chemokine interleukin-8 in response to bacterial entry. Infect Immun 61:4569–4574PubMed Eckmann L, Kagnoff MF, Fierer J (1993) Epithelial cells secrete the chemokine interleukin-8 in response to bacterial entry. Infect Immun 61:4569–4574PubMed
18.
Zurück zum Zitat Mahida YR, Makh S, Hyde S, Gray T, Borriello SP (1996) Effect of Clostridium difficile toxin A on human intestinal epithelial cells: induction of interleukin 8 production and apoptosis after cell detachment. Gut 38:337–347PubMed Mahida YR, Makh S, Hyde S, Gray T, Borriello SP (1996) Effect of Clostridium difficile toxin A on human intestinal epithelial cells: induction of interleukin 8 production and apoptosis after cell detachment. Gut 38:337–347PubMed
19.
Zurück zum Zitat Daig R, Rogler G, Aschenbrenner E, Vogl D, Falk W, Gross V, Scholmerich J, Andus T (2000) Human intestinal epithelial cells secrete interleukin-1 receptor antagonist and interleukin-8 but not interleukin-1 or interleukin-6. Gut 46:350–358CrossRefPubMed Daig R, Rogler G, Aschenbrenner E, Vogl D, Falk W, Gross V, Scholmerich J, Andus T (2000) Human intestinal epithelial cells secrete interleukin-1 receptor antagonist and interleukin-8 but not interleukin-1 or interleukin-6. Gut 46:350–358CrossRefPubMed
20.
Zurück zum Zitat Parikh AA, Moon MR, Kane CD, Salzman AL, Fischer JE, Hasselgren PO (1998) Interleukin-6 production in human intestinal epithelial cells increases in association with the heat shock response. J Surg Res 77:40–44CrossRefPubMed Parikh AA, Moon MR, Kane CD, Salzman AL, Fischer JE, Hasselgren PO (1998) Interleukin-6 production in human intestinal epithelial cells increases in association with the heat shock response. J Surg Res 77:40–44CrossRefPubMed
21.
Zurück zum Zitat McGee DW, Beagley KW, Aicher WK, McGhee JR (1993) Transforming growth factor-beta and IL-1 beta act in synergy to enhance IL-6 secretion by the intestinal epithelial cell line, IEC-6. J Immunol 151:970–978PubMed McGee DW, Beagley KW, Aicher WK, McGhee JR (1993) Transforming growth factor-beta and IL-1 beta act in synergy to enhance IL-6 secretion by the intestinal epithelial cell line, IEC-6. J Immunol 151:970–978PubMed
22.
Zurück zum Zitat Gross V, Andus T, Daig R, Aschenbrenner E, Scholmerich J, Falk W (1995) Regulation of interleukin-8 production in a human colon epithelial cell line (HT-29). Gastroenterology 108:653–661PubMed Gross V, Andus T, Daig R, Aschenbrenner E, Scholmerich J, Falk W (1995) Regulation of interleukin-8 production in a human colon epithelial cell line (HT-29). Gastroenterology 108:653–661PubMed
23.
Zurück zum Zitat Rogler G, Daig R, Aschenbrenner E, Vogl D, Schlottmann K, Falk W, Gross V, Scholmerich J, Andus T (1998) Establishment of long-term primary cultures of human small and large intestinal epithelial cells. Lab Invest 78:889–890PubMed Rogler G, Daig R, Aschenbrenner E, Vogl D, Schlottmann K, Falk W, Gross V, Scholmerich J, Andus T (1998) Establishment of long-term primary cultures of human small and large intestinal epithelial cells. Lab Invest 78:889–890PubMed
24.
Zurück zum Zitat Strober W, Ludviksson BR, Fuss IJ (1998) The pathogenesis of mucosal inflammation in murine models of inflammatory bowel disease and Crohn disease. Ann Intern Med 128:848–856PubMed Strober W, Ludviksson BR, Fuss IJ (1998) The pathogenesis of mucosal inflammation in murine models of inflammatory bowel disease and Crohn disease. Ann Intern Med 128:848–856PubMed
25.
Zurück zum Zitat Strober W, Kelsall B, Fuss I, Marth T, Ludviksson B, Ehrhardt R, Neurath M (1997) Reciprocal IFN-gamma and TGF-beta responses regulate the occurrence of mucosal inflammation. Immunol Today 18:61–64CrossRefPubMed Strober W, Kelsall B, Fuss I, Marth T, Ludviksson B, Ehrhardt R, Neurath M (1997) Reciprocal IFN-gamma and TGF-beta responses regulate the occurrence of mucosal inflammation. Immunol Today 18:61–64CrossRefPubMed
26.
Zurück zum Zitat Bregenholt S, Claesson MH (1998) Increased intracellular Th1 cytokines in SCID mice with inflammatory bowel disease. Eur J Immunol 28:379–389CrossRefPubMed Bregenholt S, Claesson MH (1998) Increased intracellular Th1 cytokines in SCID mice with inflammatory bowel disease. Eur J Immunol 28:379–389CrossRefPubMed
27.
Zurück zum Zitat Autenrieth IB, Bucheler N, Bohn E, Heinze G, Horak I (1997) Cytokine mRNA expression in intestinal tissue of interleukin-2 deficient mice with bowel inflammation. Gut 41:793–800PubMed Autenrieth IB, Bucheler N, Bohn E, Heinze G, Horak I (1997) Cytokine mRNA expression in intestinal tissue of interleukin-2 deficient mice with bowel inflammation. Gut 41:793–800PubMed
28.
Zurück zum Zitat McDonald SA, Palmen MJ, Van Rees EP, MacDonald TT (1997) Characterization of the mucosal cell-mediated immune response in IL-2 knockout mice before and after the onset of colitis. Immunology 91:73–80CrossRefPubMed McDonald SA, Palmen MJ, Van Rees EP, MacDonald TT (1997) Characterization of the mucosal cell-mediated immune response in IL-2 knockout mice before and after the onset of colitis. Immunology 91:73–80CrossRefPubMed
29.
Zurück zum Zitat Simpson SJ, Shah S, Comiskey M, de Jong YP, Wang B, Mizoguchi E, Bhan AK, Terhorst C (1998) T cell-mediated pathology in two models of experimental colitis depends predominantly on the interleukin 12/Signal transducer and activator of transcription (Stat)-4 pathway, but is not conditional on interferon gamma expression by T cells. J Exp Med 187:1225–1234CrossRefPubMed Simpson SJ, Shah S, Comiskey M, de Jong YP, Wang B, Mizoguchi E, Bhan AK, Terhorst C (1998) T cell-mediated pathology in two models of experimental colitis depends predominantly on the interleukin 12/Signal transducer and activator of transcription (Stat)-4 pathway, but is not conditional on interferon gamma expression by T cells. J Exp Med 187:1225–1234CrossRefPubMed
30.
Zurück zum Zitat Simpson SJ, de Jong YP, Comiskey M, Terhorst C (2000) Pathways of T cell pathology in models of chronic intestinal inflammation. Int Rev Immunol 19:1–37PubMed Simpson SJ, de Jong YP, Comiskey M, Terhorst C (2000) Pathways of T cell pathology in models of chronic intestinal inflammation. Int Rev Immunol 19:1–37PubMed
31.
Zurück zum Zitat Saubermann LJ, Nakajima A, Wada K, Zhao S, Terauchi Y, Kadowaki T, Aburatani H, Matsuhashi N, Nagai R, Blumberg RS (2002) Peroxisome proliferator-activated receptor gamma agonist ligands stimulate a Th2 cytokine response and prevent acute colitis. Inflamm Bowel Dis 8:330–339CrossRefPubMed Saubermann LJ, Nakajima A, Wada K, Zhao S, Terauchi Y, Kadowaki T, Aburatani H, Matsuhashi N, Nagai R, Blumberg RS (2002) Peroxisome proliferator-activated receptor gamma agonist ligands stimulate a Th2 cytokine response and prevent acute colitis. Inflamm Bowel Dis 8:330–339CrossRefPubMed
32.
Zurück zum Zitat Neurath MF, Finotto S, Glimcher LH (2002) The role of Th1/Th2 polarization in mucosal immunity. Nat Med 8:567–573CrossRefPubMed Neurath MF, Finotto S, Glimcher LH (2002) The role of Th1/Th2 polarization in mucosal immunity. Nat Med 8:567–573CrossRefPubMed
33.
Zurück zum Zitat Wirtz S, Neurath MF (2000) Animal models of intestinal inflammation: new insights into the molecular pathogenesis and immunotherapy of inflammatory bowel disease. Int J Colorectal Dis 15:144–160PubMed Wirtz S, Neurath MF (2000) Animal models of intestinal inflammation: new insights into the molecular pathogenesis and immunotherapy of inflammatory bowel disease. Int J Colorectal Dis 15:144–160PubMed
34.
Zurück zum Zitat Kolios G, Robertson DA, Jordan NJ, Minty A, Caput D, Ferrara P, Westwick J (1996) Interleukin-8 production by the human colon epithelial cell line HT-29: modulation by interleukin-13. Br J Pharmacol 119:351–359PubMed Kolios G, Robertson DA, Jordan NJ, Minty A, Caput D, Ferrara P, Westwick J (1996) Interleukin-8 production by the human colon epithelial cell line HT-29: modulation by interleukin-13. Br J Pharmacol 119:351–359PubMed
35.
Zurück zum Zitat Abreu-Martin MT, Vidrich A, Lynch DH, Targan SR (1995) Divergent induction of apoptosis and IL-8 secretion in HT-29 cells in response to TNF-alpha and ligation of Fas antigen. J Immunol 155:4147–4154PubMed Abreu-Martin MT, Vidrich A, Lynch DH, Targan SR (1995) Divergent induction of apoptosis and IL-8 secretion in HT-29 cells in response to TNF-alpha and ligation of Fas antigen. J Immunol 155:4147–4154PubMed
36.
Zurück zum Zitat Bertrand V, Quere S, Guimbaud R, Sogni P, Chauvelot-Moachon L, Tulliez M, Lamarque D, Charreire J, Giroud JP, Couturier D, Chaussade S, Breban M (1998) Effects of murine recombinant interleukin-10 on the inflammatory disease of rats transgenic for HLA-B27 and human beta 2-microglobulin. Eur Cytokine Netw 9:161–170PubMed Bertrand V, Quere S, Guimbaud R, Sogni P, Chauvelot-Moachon L, Tulliez M, Lamarque D, Charreire J, Giroud JP, Couturier D, Chaussade S, Breban M (1998) Effects of murine recombinant interleukin-10 on the inflammatory disease of rats transgenic for HLA-B27 and human beta 2-microglobulin. Eur Cytokine Netw 9:161–170PubMed
37.
Zurück zum Zitat Leach MW, Davidson NJ, Fort MM, Powrie F, Rennick DM (1999) The role of IL-10 in inflammatory bowel disease: “of mice and men”. Toxicol Pathol 27:123–133PubMed Leach MW, Davidson NJ, Fort MM, Powrie F, Rennick DM (1999) The role of IL-10 in inflammatory bowel disease: “of mice and men”. Toxicol Pathol 27:123–133PubMed
38.
Zurück zum Zitat Rogler G, Andus T (1998) Cytokines in inflammatory bowel disease. World J Surg 22:382–389PubMed Rogler G, Andus T (1998) Cytokines in inflammatory bowel disease. World J Surg 22:382–389PubMed
39.
Zurück zum Zitat Steidler L, Hans W, Schotte L, Neirynck S, Obermeier F, Falk W, Fiers W, Remaut E (2000) Treatment of murine colitis by Lactococcus lactis secreting interleukin- 10. Science 289:1352–1355CrossRefPubMed Steidler L, Hans W, Schotte L, Neirynck S, Obermeier F, Falk W, Fiers W, Remaut E (2000) Treatment of murine colitis by Lactococcus lactis secreting interleukin- 10. Science 289:1352–1355CrossRefPubMed
40.
Zurück zum Zitat Boehm U, Klamp T, Groot M, Howard JC (1997) Cellular responses to interferon-gamma. Annu Rev Immunol 15:749–795PubMed Boehm U, Klamp T, Groot M, Howard JC (1997) Cellular responses to interferon-gamma. Annu Rev Immunol 15:749–795PubMed
41.
Zurück zum Zitat Warhurst AC, Hopkins SJ, Warhurst G (1998) Interferon gamma induces differential upregulation of alpha and beta chemokine secretion in colonic epithelial cell lines. Gut 42:208–213PubMed Warhurst AC, Hopkins SJ, Warhurst G (1998) Interferon gamma induces differential upregulation of alpha and beta chemokine secretion in colonic epithelial cell lines. Gut 42:208–213PubMed
42.
Zurück zum Zitat Pechkovsky DV, Zissel G, Ziegenhagen MW, Einhaus M, Taube C, Rabe KF, Magnussen H, Papadopoulos T, Schlaak M, Muller-Quernheim (2000) Effect of proinflammatory cytokines on interleukin-8 mRNA expression and protein production by isolated human alveolar epithelial cells type II in primary culture. J. Eur Cytokine Netw 11:618–625PubMed Pechkovsky DV, Zissel G, Ziegenhagen MW, Einhaus M, Taube C, Rabe KF, Magnussen H, Papadopoulos T, Schlaak M, Muller-Quernheim (2000) Effect of proinflammatory cytokines on interleukin-8 mRNA expression and protein production by isolated human alveolar epithelial cells type II in primary culture. J. Eur Cytokine Netw 11:618–625PubMed
43.
Zurück zum Zitat Kohda F, Koga T, Uchi H, Urabe K, Furue M (2002) Histamine-induced IL-6 and IL-8 production are differentially modulated by IFN-gamma and IL-4 in human keratinocytes. J Dermatol Sci 28:34–41CrossRefPubMed Kohda F, Koga T, Uchi H, Urabe K, Furue M (2002) Histamine-induced IL-6 and IL-8 production are differentially modulated by IFN-gamma and IL-4 in human keratinocytes. J Dermatol Sci 28:34–41CrossRefPubMed
44.
Zurück zum Zitat Oliveira IC, Mukaida N, Matsushima K, Vilcek J (1994) Transcriptional inhibition of the interleukin-8 gene by interferon is mediated by the NF-kappa B site. Mol Cell Biol 14:5300–5308PubMed Oliveira IC, Mukaida N, Matsushima K, Vilcek J (1994) Transcriptional inhibition of the interleukin-8 gene by interferon is mediated by the NF-kappa B site. Mol Cell Biol 14:5300–5308PubMed
45.
Zurück zum Zitat Chavez AM, Menconi MJ, Hodin RA, Fink MP (1999) Cytokine-induced intestinal epithelial hyperpermeability: role of nitric oxide. Crit Care Med 27:2246–2251CrossRefPubMed Chavez AM, Menconi MJ, Hodin RA, Fink MP (1999) Cytokine-induced intestinal epithelial hyperpermeability: role of nitric oxide. Crit Care Med 27:2246–2251CrossRefPubMed
46.
Zurück zum Zitat Breese E, Braegger CP, Corrigan CJ, Walker-Smith JA, MacDonald TT (1993) Interleukin-2- and interferon-gamma-secreting T cells in normal and diseased human intestinal mucosa. Immunology 78:127–131PubMed Breese E, Braegger CP, Corrigan CJ, Walker-Smith JA, MacDonald TT (1993) Interleukin-2- and interferon-gamma-secreting T cells in normal and diseased human intestinal mucosa. Immunology 78:127–131PubMed
47.
Zurück zum Zitat Qin OY, el-Youssef M, Yen-Lieberman B, Sapatnekar W, Youngman KR, Kusugami K, Fiocchi C (1988) Expression of HLA-DR antigens in inflammatory bowel disease mucosa: role of intestinal lamina propria mononuclear cell-derived interferon gamma. Dig Dis Sci 33:1528–1536PubMed Qin OY, el-Youssef M, Yen-Lieberman B, Sapatnekar W, Youngman KR, Kusugami K, Fiocchi C (1988) Expression of HLA-DR antigens in inflammatory bowel disease mucosa: role of intestinal lamina propria mononuclear cell-derived interferon gamma. Dig Dis Sci 33:1528–1536PubMed
48.
Zurück zum Zitat Lieberman BY, Fiocchi C, Youngman KR, Sapatnekar WK, Proffitt MR (1988) Interferon gamma production by human intestinal mucosal mononuclear cells. Decreased levels in inflammatory bowel disease. Dig Dis Sci 33:1297–1304PubMed Lieberman BY, Fiocchi C, Youngman KR, Sapatnekar WK, Proffitt MR (1988) Interferon gamma production by human intestinal mucosal mononuclear cells. Decreased levels in inflammatory bowel disease. Dig Dis Sci 33:1297–1304PubMed
Metadaten
Titel
Interferon gamma downregulates IL-8 production in primary human colonic epithelial cells without induction of apoptosis
verfasst von
K. Schlottmann
F.-P. Wachs
J. Grossmann
D. Vogl
M. Maendel
W. Falk
J. Schölmerich
T. Andus
G. Rogler
Publikationsdatum
01.09.2004
Verlag
Springer-Verlag
Erschienen in
International Journal of Colorectal Disease / Ausgabe 5/2004
Print ISSN: 0179-1958
Elektronische ISSN: 1432-1262
DOI
https://doi.org/10.1007/s00384-003-0570-4

Weitere Artikel der Ausgabe 5/2004

International Journal of Colorectal Disease 5/2004 Zur Ausgabe

Announcements

September 2004

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.